qsar and drug design. corwen hansch developed a workable methodology quantitative structure activity...

79
QSAR AND DRUG DESIGN

Upload: liliana-norman

Post on 04-Jan-2016

226 views

Category:

Documents


3 download

TRANSCRIPT

Page 1: QSAR AND DRUG DESIGN. Corwen Hansch developed a workable methodology Quantitative Structure Activity Relationship. In 1968, Crum-Brown and Fraser published

QSAR AND DRUG DESIGN

Page 2: QSAR AND DRUG DESIGN. Corwen Hansch developed a workable methodology Quantitative Structure Activity Relationship. In 1968, Crum-Brown and Fraser published

Corwen Hansch developed a workable methodology Quantitative Structure Activity Relationship.In 1968, Crum-Brown and Fraser published an equation first general formulation of QSAR’S.

Page 3: QSAR AND DRUG DESIGN. Corwen Hansch developed a workable methodology Quantitative Structure Activity Relationship. In 1968, Crum-Brown and Fraser published

The relationship b/w chemical structure and biological activity since before the turn of the century.

Page 4: QSAR AND DRUG DESIGN. Corwen Hansch developed a workable methodology Quantitative Structure Activity Relationship. In 1968, Crum-Brown and Fraser published

On different alkaloids the alkylation of the basic nitrogen atom produced different biological effects quarternery ammonium compouns

Biological activity is a function of the chemical structure

BA = f ( C) ….. (1)

Page 5: QSAR AND DRUG DESIGN. Corwen Hansch developed a workable methodology Quantitative Structure Activity Relationship. In 1968, Crum-Brown and Fraser published

Richet discovered that the toxicity of organic compounds inversely proportional to water solubility.

So changing biological activity (ΔBA ) corresponds to the change in the chemical and physiochemical properties.

ΔBA= f (ΔC ) ------ (2)

Page 6: QSAR AND DRUG DESIGN. Corwen Hansch developed a workable methodology Quantitative Structure Activity Relationship. In 1968, Crum-Brown and Fraser published

All the QSAR equation corresponds to eqn 2,because only difference in BA quantitatively correlates with changes in lipophilicity of the compound under investigation.

QSAR involves the derivation of mathematical formula which relates the biological activities of a group of compounds to their measurable physiochemical parameters.

Page 7: QSAR AND DRUG DESIGN. Corwen Hansch developed a workable methodology Quantitative Structure Activity Relationship. In 1968, Crum-Brown and Fraser published

These parameters have major influence on drug’s activity.

Biological activity= function(parameters)Activity is expressed as log(1/c),c is the

minimum concentration required to cause a defined biological response.

QSAR based on Hammet’s constant uses eletronic properties as the descriptors of structures.

Page 8: QSAR AND DRUG DESIGN. Corwen Hansch developed a workable methodology Quantitative Structure Activity Relationship. In 1968, Crum-Brown and Fraser published

The importance of lipophilicity expressed as octanol-water partition coefficient on biological activity.

This parameter provides a measure of bioavailability to compounds which will determine the amt of compounds that reaches the target site.

Page 9: QSAR AND DRUG DESIGN. Corwen Hansch developed a workable methodology Quantitative Structure Activity Relationship. In 1968, Crum-Brown and Fraser published

All these reveal that biological activity of a drug is a function of chemicalfeatures(lipophilicity,electronic and steric) of the substituents and skeleton of the molecule.

Lipophilicity is the major factor governing transport,distribution and metabolism of the drug in biological system.

Page 10: QSAR AND DRUG DESIGN. Corwen Hansch developed a workable methodology Quantitative Structure Activity Relationship. In 1968, Crum-Brown and Fraser published

Electronic and steric features influence the metabolism and pharmacodynamic process of the drug.

A major problem in QSAR studies arise because hydrophobic,electronic and steric effect overlaps and cannot be separated.

Page 11: QSAR AND DRUG DESIGN. Corwen Hansch developed a workable methodology Quantitative Structure Activity Relationship. In 1968, Crum-Brown and Fraser published

Parameters Parameters assigned to various

chemical grps that can be used to modify the structure of a drug.

The parameter is a measure of the potential contribution of chemical group to a particular property of the parent drug.

Page 12: QSAR AND DRUG DESIGN. Corwen Hansch developed a workable methodology Quantitative Structure Activity Relationship. In 1968, Crum-Brown and Fraser published

Various parameters used are 1)Lipophilic parametersPartitioncoefficient,Chromatographic parameters and

π – Substitution constant.

Page 13: QSAR AND DRUG DESIGN. Corwen Hansch developed a workable methodology Quantitative Structure Activity Relationship. In 1968, Crum-Brown and Fraser published

ii)Polarizability parameters: Molar refractivity(MR),Molarvolume, Parachor. iii)Electronic parameters: Hammett Constant, Field and resonance

parameters, parameters derived from spectroscopic data, Charge-transfer constant, Dipole moment, Quantum chemical parameters.

Page 14: QSAR AND DRUG DESIGN. Corwen Hansch developed a workable methodology Quantitative Structure Activity Relationship. In 1968, Crum-Brown and Fraser published

iv)Steric parameters: Taft’s steric constant,Vanderwaal’s

radii.v) Miscellaneous parameters :

Molecular weight,Geometric parameters,Conformational entropies,Connectivity indices and other topological parameters.

Page 15: QSAR AND DRUG DESIGN. Corwen Hansch developed a workable methodology Quantitative Structure Activity Relationship. In 1968, Crum-Brown and Fraser published

Lipophilic parameters Lipophilicity is defined as the

partitioning of a compound between an aqueous and a nonqueous phase

Partition coefficient (p) and lipophilic substituent(π).

Page 16: QSAR AND DRUG DESIGN. Corwen Hansch developed a workable methodology Quantitative Structure Activity Relationship. In 1968, Crum-Brown and Fraser published

Partition Coefficient A drug passes through a no of

biological membranes to reach its site of action.

The movement of drug through these membranes measured by

P= COrganic/ Caqueous……..(3)

Page 17: QSAR AND DRUG DESIGN. Corwen Hansch developed a workable methodology Quantitative Structure Activity Relationship. In 1968, Crum-Brown and Fraser published

It is the ratio of concentration of the substance in organic and aqueous

phase of a two compartment system under equillibrium conditions.

For easily ionisable drug P= COrganic/ Caqueous(1-α )

Alpha is the degree of ionisation.

Page 18: QSAR AND DRUG DESIGN. Corwen Hansch developed a workable methodology Quantitative Structure Activity Relationship. In 1968, Crum-Brown and Fraser published

The acuracy of correlation of drug activity wit coefficient will depend on the solvent system used as a model for the membrane.

Both pure and buffered soln used for the aqueous soln.The n-octanol water system is

frequently chosen,because it appears to be a good mimic of lipid polarity.

Page 19: QSAR AND DRUG DESIGN. Corwen Hansch developed a workable methodology Quantitative Structure Activity Relationship. In 1968, Crum-Brown and Fraser published

n-octanol more constistent results for drugs

absorbed in GI tract less polar solvents such as olive oil

give more consistent correlation of drugs crossing the blood brain barrier.

Page 20: QSAR AND DRUG DESIGN. Corwen Hansch developed a workable methodology Quantitative Structure Activity Relationship. In 1968, Crum-Brown and Fraser published

n-octanol has a low vapour pressure,allowing reproducible measurements.

N-octanol is a UV transaparent over a large range making the

quantitative detemination of a compound very easy.

Page 21: QSAR AND DRUG DESIGN. Corwen Hansch developed a workable methodology Quantitative Structure Activity Relationship. In 1968, Crum-Brown and Fraser published

More polar solvents such as chloroform gives more consistent value for buccal absorption.

It is a suitable model of the lipid constituents of biological membrane due to its long alkyl chain and the polar hydroxyl grp.

Page 22: QSAR AND DRUG DESIGN. Corwen Hansch developed a workable methodology Quantitative Structure Activity Relationship. In 1968, Crum-Brown and Fraser published

The former parameter refers to the whole molecule while the latter related to substituted groups.

Chromatographic Parameters When the solubility of a solute is

considerably greater in 1st phase than the other ,partition coefficient becomes difficult to determine experimentally.

Chromatographic parameters obtained from RP thin layer chromatography are occassionaly used as substitutes for partition coefficient.

Page 23: QSAR AND DRUG DESIGN. Corwen Hansch developed a workable methodology Quantitative Structure Activity Relationship. In 1968, Crum-Brown and Fraser published

Silica gel plate coated with hydrophobic phase is eluted with aqueous/organic solvent system of increasing water content.

Rf values are converted to Rm values which are the true measure of lipophilicity from the following equation

Rm = Log(1/Rf-1)

Page 24: QSAR AND DRUG DESIGN. Corwen Hansch developed a workable methodology Quantitative Structure Activity Relationship. In 1968, Crum-Brown and Fraser published

The Rm values offer advantages compared to log P values.

Used as substitute for partition coefficient in QSAR investigations.

a)Compounds need not be pure. b) Only traces of materials needed c) A wide range of hydrophilic and hydrophobic

congeners can be investigated d) The measurement of practicaly insoluble analogs

possess no problem e) No quantitative method for concentration determination needed f) Several compounds can be estimated simultaneously

Page 25: QSAR AND DRUG DESIGN. Corwen Hansch developed a workable methodology Quantitative Structure Activity Relationship. In 1968, Crum-Brown and Fraser published

The main disadvantages are a) Lack of precision and

reproducibility b) Use of different organic solvent

system renders the derivation of π and f related scales impossible.

Page 26: QSAR AND DRUG DESIGN. Corwen Hansch developed a workable methodology Quantitative Structure Activity Relationship. In 1968, Crum-Brown and Fraser published

Π Substituent constant/Lipophilic Substituent constant

Lipophilic substituent constant are also known as hydrophobic constants (Π)

The Π substituent constant defined by Hansch and Co-workers by the equation

Π= log PRH- log PRX

Where PRH and PRX are the partition coefficient of the std compound and its monosubstituted derivative respectively.

Page 27: QSAR AND DRUG DESIGN. Corwen Hansch developed a workable methodology Quantitative Structure Activity Relationship. In 1968, Crum-Brown and Fraser published

Calculation of Log P value of m-chlorotoluene is given as

log P= log P benzene + π Cl + π me

= 2.13+0.71+0.56=3.40log P= log P toluene + π me- Cl

= 2.69+0.76 =3.45log P= log P chlorobenzene + π meta- Me

= 2.84+0.51=3.35logP exp = 3.28

Page 28: QSAR AND DRUG DESIGN. Corwen Hansch developed a workable methodology Quantitative Structure Activity Relationship. In 1968, Crum-Brown and Fraser published

Polarizability parameters Molar Refractivity(MR)It is a measure of both the volume of a compound and

how easily it is polarized It is expressed as MR = (n2-1)Mw (n2-1) dWhere n is the refractive iondex M is the molecular weight d is the density

Page 29: QSAR AND DRUG DESIGN. Corwen Hansch developed a workable methodology Quantitative Structure Activity Relationship. In 1968, Crum-Brown and Fraser published

The term Mw/d define a volume ,while the term (n2-1) / (n2+ 2) indicates a correction factor by indicating how easily the substituent can be polarised.

This is particularly significant if the substituent has a π electron or lone pair of electrons.

Page 30: QSAR AND DRUG DESIGN. Corwen Hansch developed a workable methodology Quantitative Structure Activity Relationship. In 1968, Crum-Brown and Fraser published

Ligand –enzyme inter

The significance of molar refractivity terms in QSAR equation of ligand-enzyme interaction could be interpreted with the help of 3D structure.The investigation shows that substituent modelled by MR bind in polar areas while π,bind in hydrophobic space.

Page 31: QSAR AND DRUG DESIGN. Corwen Hansch developed a workable methodology Quantitative Structure Activity Relationship. In 1968, Crum-Brown and Fraser published

The positive sign of MR in QSAR equation indicates that substituent binds to polar surface while a – ve sign or nonlinear relationship indicates steric hindrance at the binding sites.

Page 32: QSAR AND DRUG DESIGN. Corwen Hansch developed a workable methodology Quantitative Structure Activity Relationship. In 1968, Crum-Brown and Fraser published

Electronic Parameters The distribution of electron in a drug

molecule has considerable influence on the distribution and activity of the drug.

Polar and nonpolar drug unionized form are transported through the membrane than polar drugs in their ionized form.

Page 33: QSAR AND DRUG DESIGN. Corwen Hansch developed a workable methodology Quantitative Structure Activity Relationship. In 1968, Crum-Brown and Fraser published

If the drug reaches the target site, the distributed electron will control the type of bond that it forms with the target site,which inturn affects its biological activity.

The Hammet Constant (σ) He quantified the electronic effects of groups

on the physiochemical properties of the cpd. The distribution of the elecrons within a

molecule depends on the nature of the electron withdrawing and donating group found in the structure.

Page 34: QSAR AND DRUG DESIGN. Corwen Hansch developed a workable methodology Quantitative Structure Activity Relationship. In 1968, Crum-Brown and Fraser published

Hammett used this concept to calculate Hammet constant(σ)for a variety of monosubstituted benzoic acids.

These constants were used to calculate the equillibrium constants for chemical reactions.

σ=log KBx

KB

Page 35: QSAR AND DRUG DESIGN. Corwen Hansch developed a workable methodology Quantitative Structure Activity Relationship. In 1968, Crum-Brown and Fraser published

ie., σx= log KBx-log KB

pka= -log Ka

σx=pKB-pKBx

Where KB and KBx are the equillibrium constants for benzoic acids and monosubstituted benzoic acids respectively.

Page 36: QSAR AND DRUG DESIGN. Corwen Hansch developed a workable methodology Quantitative Structure Activity Relationship. In 1968, Crum-Brown and Fraser published

Hammett substituent const is a measure of the electron withdrawing or donating ability of a substituent and is determined by comparing the dissociation of a series of substituted acid with that of the parent or unsubstituted acid

Page 37: QSAR AND DRUG DESIGN. Corwen Hansch developed a workable methodology Quantitative Structure Activity Relationship. In 1968, Crum-Brown and Fraser published

A negative value of σx indicates that the substituent is acting as an electron donor and the +ve value indicates that it is acting as a electron withdrawing group.

Hammett constant take into acount both resonance and inductive effect

Page 38: QSAR AND DRUG DESIGN. Corwen Hansch developed a workable methodology Quantitative Structure Activity Relationship. In 1968, Crum-Brown and Fraser published

The values for σ for a particular substituent varies depending on their substitution meta or para.

The meta and para sigma value are commonly used and indicated by a subscript m or p after the symbol ,

The o – substituent are unreliable due to steric hindrance and other effects such as intramolecular hydrogen bonding.

Page 39: QSAR AND DRUG DESIGN. Corwen Hansch developed a workable methodology Quantitative Structure Activity Relationship. In 1968, Crum-Brown and Fraser published

3 Kinds of static or electical influence states predominates

Resonance or Mesomeric effect Inductive effect. Electrical effect which is transmitted

by the polarization of electrons from atom to another.

Page 40: QSAR AND DRUG DESIGN. Corwen Hansch developed a workable methodology Quantitative Structure Activity Relationship. In 1968, Crum-Brown and Fraser published

Hammett Constant Inductive effect---- Intrinsic tendency of a

substituent to withdraw or release electns.

For eg G releases e-ns ,disperses charge and stabilises cation.

G C+

Page 41: QSAR AND DRUG DESIGN. Corwen Hansch developed a workable methodology Quantitative Structure Activity Relationship. In 1968, Crum-Brown and Fraser published

G withdraws e-ns intensifies the charge and destabilizes the cation.

G C +

Page 42: QSAR AND DRUG DESIGN. Corwen Hansch developed a workable methodology Quantitative Structure Activity Relationship. In 1968, Crum-Brown and Fraser published

Disadvantage:They only apply to substituent directly

attached to benzene ring.If there is more than one substituent the

value are summarized as Σσ. This constant was unsuccessful to relate biological activity sine the electron distribution is not the only factor involved.

Page 43: QSAR AND DRUG DESIGN. Corwen Hansch developed a workable methodology Quantitative Structure Activity Relationship. In 1968, Crum-Brown and Fraser published

Inductive substituent Constant:Hammett constant are a measure of both

inductive and mesomeric effect.The para substituent constant (σp) has a

greater resonance component than the equivalent meta constant (σm) and the inductive const can be calculated from the inductive substituent constant (σi)

σi= ½ (3 σp- σm)

Page 44: QSAR AND DRUG DESIGN. Corwen Hansch developed a workable methodology Quantitative Structure Activity Relationship. In 1968, Crum-Brown and Fraser published

It is used in aliphatic compound where influencing and influenced form group do not form a part of the conjugated system.

Taft’s substituent constant( σ*)It is a measure of the polar effects of a

substituent in aliphatic compound.They are based on the hydrolysis of ester

and calculated frm the following eqn

Page 45: QSAR AND DRUG DESIGN. Corwen Hansch developed a workable methodology Quantitative Structure Activity Relationship. In 1968, Crum-Brown and Fraser published

σ*= 1 log(k/ko)B - log(k/ko)A

2.48ie, 0.403 log(k/ko)B - log(k/ko)A

Where k is the rate constants for the hydrolysis of substituted compound.

Ko those of methyl derivative .

B represents basic hydrolysis and A acid hydrolysis respectively.

Page 46: QSAR AND DRUG DESIGN. Corwen Hansch developed a workable methodology Quantitative Structure Activity Relationship. In 1968, Crum-Brown and Fraser published

The factor 1/2.48 is a constant B is influenced by the polar effect so that

by substracting the acid term from the basic term only the polar effect remain.

In taft’s substituent constant only the methyl group is the standard for which the constant is zero.

Page 47: QSAR AND DRUG DESIGN. Corwen Hansch developed a workable methodology Quantitative Structure Activity Relationship. In 1968, Crum-Brown and Fraser published

That can be compared with other constant by writing the methyl group in the form CH2-H and identify it as the group for H.

Taft and Inductive substituent constant are related as

σ*= 2.51 σi

Page 48: QSAR AND DRUG DESIGN. Corwen Hansch developed a workable methodology Quantitative Structure Activity Relationship. In 1968, Crum-Brown and Fraser published

Steric Substitution Constant

The drug approaches the binding site to interact with the receptor.The bulk,size and shape of the drug may influence on this process.

A steric substitution constant is a measure of the bulkiness of the grp it represents and its effect on the closeness of the group between the drug and receptor site.

Page 49: QSAR AND DRUG DESIGN. Corwen Hansch developed a workable methodology Quantitative Structure Activity Relationship. In 1968, Crum-Brown and Fraser published

CHARTON’S STERIC CONSTANT

Corrected Vanderwaal’s radius U in which the minimum Vanderwaal’s radii of the substituent grp (rv(min) is corrected for the corresponding radius for hydrogen(rvH),

Page 50: QSAR AND DRUG DESIGN. Corwen Hansch developed a workable methodology Quantitative Structure Activity Relationship. In 1968, Crum-Brown and Fraser published

U= rv(min)-rvH= rv(min) -1.20

Page 51: QSAR AND DRUG DESIGN. Corwen Hansch developed a workable methodology Quantitative Structure Activity Relationship. In 1968, Crum-Brown and Fraser published

Other parameters Molecular wt was used by Lien to

improve the fit of parabolic Hansch equation .A more appropriate use of MW was demonstrated in the QSAR study of multidrug resistance of tumour cells,where MW stands for

the dependence of biological activities on diffusion rate constant.

Page 52: QSAR AND DRUG DESIGN. Corwen Hansch developed a workable methodology Quantitative Structure Activity Relationship. In 1968, Crum-Brown and Fraser published

The relationship bw MW and volume implies that 3√MW correponding to linear dimension of size should be better than log MW.

Indicator variables known as dummy variables or de-nova constant are used in linear multiple regression analysis .It is used to account for other structural features

Page 53: QSAR AND DRUG DESIGN. Corwen Hansch developed a workable methodology Quantitative Structure Activity Relationship. In 1968, Crum-Brown and Fraser published

1.Intramolecular hydrogen bonding,hydrogen donor & acceptor properties,ortho effects,cis/trans isomers,diff parent skeleton,diff test models etc.

Page 54: QSAR AND DRUG DESIGN. Corwen Hansch developed a workable methodology Quantitative Structure Activity Relationship. In 1968, Crum-Brown and Fraser published

Quantitative ModelsThis is the most popular mathematical approach to

QSAR introduced by Hansch.a) Transport of drug to its site of action.b) The binding of drug to its target site. Each of these stages depends on the chemical and physical properties of the drug and its target site.In Hansch analysis these properties are described by the parameters which correlates biological activity.

Page 55: QSAR AND DRUG DESIGN. Corwen Hansch developed a workable methodology Quantitative Structure Activity Relationship. In 1968, Crum-Brown and Fraser published

The most commonly used physiochemical parameters for Hansch analysis are logp,Π, σ and steric parameters are practically all the parameters used in Hansch analysis are linear free energy related ,so it is known as linear free energy approach or extra thermodynamical approach.

Page 56: QSAR AND DRUG DESIGN. Corwen Hansch developed a workable methodology Quantitative Structure Activity Relationship. In 1968, Crum-Brown and Fraser published

The relnship b/w P and drug activity depends on P values.If range is low,straight line is

obtained.log1 /c = K1log p +K2

Where K1 and K2 are consts.

Page 57: QSAR AND DRUG DESIGN. Corwen Hansch developed a workable methodology Quantitative Structure Activity Relationship. In 1968, Crum-Brown and Fraser published

If the hydrophobicity values are limited to a small values then the eqn will be linear.

log1 /c = k1log p +k2 σ+K3E3+ K4

Where K1,K2,K3 are constant obtained by least square procedure.

Page 58: QSAR AND DRUG DESIGN. Corwen Hansch developed a workable methodology Quantitative Structure Activity Relationship. In 1968, Crum-Brown and Fraser published

C is the molar concentration that produces biological action.

The molecule which are too hydrophilic or lipophilic will not be able to cross the lipophilic or hydrophilic barriers respectively.

If the P value are higher range ,then the equation will be parabolic and given as

Page 59: QSAR AND DRUG DESIGN. Corwen Hansch developed a workable methodology Quantitative Structure Activity Relationship. In 1968, Crum-Brown and Fraser published

log1/c =-K1 (logp)2 +K2logP+

K3 σ+K4εS+K5

The constants K1-K5 are obtained by least square method.

Here the graph of log 1/c against log P

Have max values logP0 ---- parabolic form

Page 60: QSAR AND DRUG DESIGN. Corwen Hansch developed a workable methodology Quantitative Structure Activity Relationship. In 1968, Crum-Brown and Fraser published

Below the P0 – drug reluctant to enter the membrane.

Above P0--- reluctant to leave the membrane.

The analogues with partition coeff near this optimum value ---- most active and important to study.

Page 61: QSAR AND DRUG DESIGN. Corwen Hansch developed a workable methodology Quantitative Structure Activity Relationship. In 1968, Crum-Brown and Fraser published

HANCH RULES

Selection of independent variables Different parameters 1. log P,Π, σ,MR, steric 2.Parameters should be independent.The intercorrelation coefficient should

not be larger than 0.6-0.7.

Page 62: QSAR AND DRUG DESIGN. Corwen Hansch developed a workable methodology Quantitative Structure Activity Relationship. In 1968, Crum-Brown and Fraser published

All the reasonable parameters must be validated by appropriate statistical procedure ie either by a step wise regression analysis or cross validation.

Page 63: QSAR AND DRUG DESIGN. Corwen Hansch developed a workable methodology Quantitative Structure Activity Relationship. In 1968, Crum-Brown and Fraser published

The best equation is normally one with lower standard deviation and higher F value.

Page 64: QSAR AND DRUG DESIGN. Corwen Hansch developed a workable methodology Quantitative Structure Activity Relationship. In 1968, Crum-Brown and Fraser published

If all the equations are equal simplest one is taken

Number of variable should be at least 5 or 6 data point per variable to avoid chance correlations.

Model should be consistent with the known physical.organic and bio-medicinal chemistry of the process under consider consideration.

Page 65: QSAR AND DRUG DESIGN. Corwen Hansch developed a workable methodology Quantitative Structure Activity Relationship. In 1968, Crum-Brown and Fraser published

APPLICATIONS OF HANCH ANALYSIS

It is used to predict the activity of an yet unsynthesised analogue.

This enables the medicinal chemist to synthesise an analogue which is worthy.

Page 66: QSAR AND DRUG DESIGN. Corwen Hansch developed a workable methodology Quantitative Structure Activity Relationship. In 1968, Crum-Brown and Fraser published

Eg; The adrenergic activity of a series of analogues of β-haloarylamine was observed.

It was found that only pi and sigma values only related to activity and not the steric factor.

Log 1/c =1.78pi+1.674

Page 67: QSAR AND DRUG DESIGN. Corwen Hansch developed a workable methodology Quantitative Structure Activity Relationship. In 1968, Crum-Brown and Fraser published

Hansch analysis may also used to give an indication of the importance of the influence of parameters on the mechanism by which a drug acts.

Page 68: QSAR AND DRUG DESIGN. Corwen Hansch developed a workable methodology Quantitative Structure Activity Relationship. In 1968, Crum-Brown and Fraser published

The smaller the value of coefficient of σ relative to that of Π in tha above eqn shows that electronic effect do not play an important role in the action of the drug.

The accuracy of Hansch equation depends on

1)The no of analogues used

Page 69: QSAR AND DRUG DESIGN. Corwen Hansch developed a workable methodology Quantitative Structure Activity Relationship. In 1968, Crum-Brown and Fraser published

2) The greater the number, the higher the probability of obtaining an accurate Hansch equation.

3)The accuracy of biological data used in the derivation of the equation.

4)The choice of parameters.

Page 70: QSAR AND DRUG DESIGN. Corwen Hansch developed a workable methodology Quantitative Structure Activity Relationship. In 1968, Crum-Brown and Fraser published

Free Wilson AnalysisIt is a true SAR model.This is an alternative

approach to Hamett model.Free and Wilson used a series of substituent

constant which related biological activity to the presence of a specific functional group at a specific location on the parent molecule.

Page 71: QSAR AND DRUG DESIGN. Corwen Hansch developed a workable methodology Quantitative Structure Activity Relationship. In 1968, Crum-Brown and Fraser published

The relationship between biological activity and the presence or absence of a substituent is expressed by the following equation

Activity=A+Gij Xij

Where A is average biological activity of the series,Gij is the contribution

Page 72: QSAR AND DRUG DESIGN. Corwen Hansch developed a workable methodology Quantitative Structure Activity Relationship. In 1968, Crum-Brown and Fraser published

of actiivity to the functional grp i in the jth position and Xij the presence or absence of functional grp i in the jth position.

Whole molecular descriptors Some of the natural

Page 73: QSAR AND DRUG DESIGN. Corwen Hansch developed a workable methodology Quantitative Structure Activity Relationship. In 1968, Crum-Brown and Fraser published

The method is based upon an additive mathematical model in which a particular substituent in a particular molecular position is assumed to make an additive and constant contribution to biological activity of a molecule in a series of chemically related molecule.

Page 74: QSAR AND DRUG DESIGN. Corwen Hansch developed a workable methodology Quantitative Structure Activity Relationship. In 1968, Crum-Brown and Fraser published

Mathematical model,Additive model or denovo approach are the synonyms for free wilsonmethod.

The substituent constant based on activities are used rather than physical properties

Page 75: QSAR AND DRUG DESIGN. Corwen Hansch developed a workable methodology Quantitative Structure Activity Relationship. In 1968, Crum-Brown and Fraser published

Introduction of a particular substituent at a particular molecular position always lead to a quantitatively similar effect on biological potency of the whole molecules and expressed by the eqn as

BA=µ+Σaij

Page 76: QSAR AND DRUG DESIGN. Corwen Hansch developed a workable methodology Quantitative Structure Activity Relationship. In 1968, Crum-Brown and Fraser published

Where µ= contribution of unsubstituted compounds

Σaij = contribution of substituted compounds

i = number of position the substituent occurs

j = number of substituent at that position

Page 77: QSAR AND DRUG DESIGN. Corwen Hansch developed a workable methodology Quantitative Structure Activity Relationship. In 1968, Crum-Brown and Fraser published

APPLICATION

1)Easy to apply2)Simple method to derive the

substituent contribution and to have a first look on their possible dependence on different physiochemical properties

Page 78: QSAR AND DRUG DESIGN. Corwen Hansch developed a workable methodology Quantitative Structure Activity Relationship. In 1968, Crum-Brown and Fraser published

The substituent which cannot fulfill the principle of additivity can be recognized.

Substituent constants like σ and Π were not considered and so this method is effective when substituent constants are not available.

Page 79: QSAR AND DRUG DESIGN. Corwen Hansch developed a workable methodology Quantitative Structure Activity Relationship. In 1968, Crum-Brown and Fraser published

DisadvantagesThe structural variation is necessary

in at least two different position of the substitution.

Large no of parameter is necessary to describe relatively few compounds.

Only a small no of new nalogues can be predicted.